Page last updated: 2024-10-26

diclofenac and Carcinoma, Ductal, Pancreatic

diclofenac has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liu, W1
Yu, X1
Yuan, Y1
Feng, Y1
Wu, C1
Huang, C1
Xie, P1
Li, S1
Li, X1
Wang, Z1
Qi, L1
Chen, Y1
Shi, L1
Li, MJ1
Huang, Z1
Tang, B1
Chang, A1
Hao, J1

Other Studies

1 other study available for diclofenac and Carcinoma, Ductal, Pancreatic

ArticleYear
CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023, Volume: 10, Issue:6

    Topics: Carcinoma, Pancreatic Ductal; Diclofenac; Gemcitabine; Humans; Nucleotidases; Pancreatic Neoplasms

2023